StockNews.com Begins Coverage on OncoCyte (NASDAQ:OCX)

StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report published on Saturday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC lowered their price objective on OncoCyte from $9.00 to $4.25 and set a buy rating for the company in a research report on Thursday, […]

Related Keywords

United States , ,Oncocyte Corporation ,Goldman Sachs Group Inc ,Raymond James Financial Services Advisors Inc ,Needham Company ,Vanguard Group Inc ,Free Report ,Cyte Stock Down ,James Financial Services Advisors ,Sachs Group ,Get Free Report ,Cyte Corporation ,Oncocyte Daily ,Oncocyte ,Nasdaq Ocx ,Socx ,Medical ,Initiated Coverage ,Stocknews Com ,